NCT06013345View on ClinicalTrials.gov

COnventional Vs. Optimised PERiprocedural Analgosedation Vs. Total IntraVEnous Anaesthesia for Pulsed-Field Ablation (COOPERATIVE-PFA)

PHASE3CompletedINTERVENTIONAL

Enrollment

127

Participants

Timeline

Start Date

October 25, 2023

Primary Completion Date

September 30, 2024

Study Completion Date

December 1, 2024

Conditions

Atrial Fibrillation

Interventions

DRUG

Remimazolam

analgosedation without secured airway

DRUG

Propofol

analgosedation with secured airway

DRUG

Propofol

TIVA with secured airway

Trial Locations (1)

10034

University Hospital Kralovske Vinohrady, Prague

All Listed Sponsors

lead

Charles University, Czech Republic

OTHER

NCT06013345 - COnventional Vs. Optimised PERiprocedural Analgosedation Vs. Total IntraVEnous Anaesthesia for Pulsed-Field Ablation (COOPERATIVE-PFA) | Biotech Hunter | Biotech Hunter